ACA
Avoro Capital Advisors Portfolio holdings
AUM
$5.71B
This Quarter Return
+22.32%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$2.09B
AUM Growth
+$2.09B
(+36%)
Cap. Flow
+$414M
Cap. Flow
% of AUM
19.84%
Top 10 Holdings %
Top 10 Hldgs %
59.98%
Holding
59
New
13
Increased
21
Reduced
6
Closed
7
Top Buys
| 1 |
Puma Biotechnology
PBYI
|
$56.2M |
| 2 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
$51.8M |
| 3 |
Iovance Biotherapeutics
IOVA
|
$47.7M |
| 4 |
ARMO
ARMO BioSciences, Inc. Common Stock
ARMO
|
$45.2M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$42.3M |
Top Sells
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
$57.9M |
| 2 |
Bristol-Myers Squibb
BMY
|
$28M |
| 3 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$16.8M |
| 4 |
CASC
Cascadian Therapeutics, Inc.
CASC
|
$9.2M |
| 5 |
AGEN
Agenus
AGEN
|
$8.17M |
Sector Composition
| 1 | Healthcare | 83.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
1
DELISTED
Immunomedics Inc
IMMU
| $247M | 11.82% | 16,939,461 +875,000 | +5% | +$12.8M |
|
2
Amicus Therapeutics
FOLD
$2.34B
| $143M | 6.83% | 9,505,447 +2,242,325 | +31% | +$33.7M |
|
|
3
BioMarin Pharmaceuticals
BMRN
$11.2B
| $139M | 6.62% | 1,710,995 +521,471 | +44% | +$42.3M |
|
|
4
Iovance Biotherapeutics
IOVA
$807M
| $137M | 6.52% | 8,078,505 +2,825,055 | +54% | +$47.7M |
|
|
MRTX
5
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $135M | 6.45% | 4,398,101 | – | – |
|
6
Ascendis Pharma
ASND
$11.8B
| $135M | 6.44% | 2,063,336 +382,312 | +23% | +$25M |
|
|
GBT
7
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $85.3M | 4.07% | 1,765,548 -76,348 | -4% | -$3.69M |
|
|
AVXS
8
DELISTED
AveXis, Inc. Common Stock
AVXS
| $83.4M | 3.99% | 675,262 +79,045 | +13% | +$9.77M |
|
9
TG Therapeutics
TGTX
$4.65B
| $74.3M | 3.55% | 5,229,619 +1,935,156 | +59% | +$27.5M |
|
|
HZNP
10
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $73.3M | 3.5% | 5,158,683 +722,500 | +16% | +$10.3M |
|
11
argenx
ARGX
$43.6B
| $69.4M | 3.32% | 863,275 +58,400 | +7% | +$4.7M |
|
|
CLVS
12
DELISTED
Clovis Oncology, Inc.
CLVS
| $61.6M | 2.94% | 1,165,884 +63,000 | +6% | +$3.33M |
|
|
13
Puma Biotechnology
PBYI
$254M
| $56.2M | 2.68% | +825,368 | New | +$56.2M |
|
|
MDCO
14
DELISTED
Medicines Co
MDCO
| $53.9M | 2.57% | 1,635,817 +339,257 | +26% | +$11.2M |
|
15
Assembly Biosciences
ASMB
$190M
| $53.8M | 2.57% | 1,093,934 +25,400 | +2% | +$1.25M |
|
16
Pacira BioSciences
PCRX
$1.2B
| $53.4M | 2.55% | 1,715,072 +866,500 | +102% | +$27M |
|
|
ECYT
17
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $51.8M | 2.47% | +5,695,200 | New | +$51.8M |
|
|
ZGNX
18
DELISTED
Zogenix, Inc.
ZGNX
| $47.6M | 2.27% | 1,189,213 -74,100 | -6% | -$2.97M |
|
19
Vanda Pharmaceuticals
VNDA
$279M
| $46.8M | 2.23% | 2,775,191 +1,366,245 | +97% | +$23M |
|
|
ARMO
20
DELISTED
ARMO BioSciences, Inc. Common Stock
ARMO
| $45.2M | 2.16% | +1,207,500 | New | +$45.2M |
|
21
Dynavax Technologies
DVAX
$1.19B
| $32.8M | 1.56% | +1,650,700 | New | +$32.8M |
|
|
ARRY
22
DELISTED
Array Biopharma Inc
ARRY
| $31.4M | 1.5% | 1,922,655 -3,545,374 | -65% | -$57.9M |
|
|
DERM
23
DELISTED
Dermira, Inc.
DERM
| $27.4M | 1.31% | 3,427,378 +1,907,378 | +125% | +$15.2M |
|
24
Gyre Therapeutics
GYRE
$703M
| $26.4M | 1.26% | 1,024,124 +624,124 | +156% | +$16.1M |
|
25
AstraZeneca
AZN
$248B
| $26.2M | 1.25% | 750,300 | – | – |
|